Select Drug Profiles

Original Research

Impact of Nonadherence to Inhaled Corticosteroid/LABA Therapy on COPD Exacerbation Rates and Healthcare Costs in a Commercially Insured US Population

Jill R. Davis, MS, Bingcao Wu, MS, David M. Kern, PhD, Ozgur Tunceli, PhD, Kathleen M. Fox, PhD, John Horton, MS, Randall F. Legg, PharmD, MBA, Frank Trudo, MD, MBA

Jill R. Davis, MS; Bingcao Wu, MS; David M. Kern, PhD; Ozgur Tunceli, PhD; Kathleen M. Fox, PhD; John Horton, MS; Randall F. Legg, PharmD, MBA; Frank Trudo, MD, MBA

Stakeholder Perspective

When an Outcome Is Overdetermined: Nonadherence, Utilization, and the Impetus for Research in COPD

Michael F. Murphy, MD, PhD

by Michael F. Murphy, MD, PhD

Perspectives

Reflections, Predictions, and Admonitions

David B. Nash, MD, MBA

Original Research, Practice Management

Does a Free Office Visit Affect Primary Care–Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi

Bettina M. Beech, DrPH, MPH, Tristan Cordier, MPH, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD

Bettina M. Beech, DrPH, MPH; Tristan Cordier, MPH; Laura E. Happe, PharmD, MPH; Laura Trunk, MD; Gilbert S. Haugh, MS; Richard Kwong, MPH; Vipin Gopal, PhD; Roy A. Beveridge, MD

Stakeholder Perspective

Patients’ Choice for Site of Care Motivated by More Than Cost Alone

James T. Kenney, Jr, RPh, MBA

by James T. Kenney, RPh, MBA

FDA Approvals, Payers' Guide

FDA Approvals of Brand-Name Prescription Drugs in 2016

FDA Approvals, Payers' Guide

Welcome to the Eighth Annual Payers’ Guide to New FDA Approvals

Payers' Guide, FDA Approvals

Darzalex (Daratumumab) Approved as Part of a 3-Drug Regimen for Patients with Multiple Myeloma

Lisa A. Raedler, PhD, RPh

Payers' Guide, FDA Approvals